s.antonsen
TL2 Moderator · Groningen
Contributes reviews on supplier material. Based in Groningen.
Joined 30 July 2025 · last posted 2d
89 posts, newest first. Showing up to 150.
-
Aggregate verification data across the directory, with caveats Replied, post #72 · Sourcing › Independent verification · 26 Jul 2026 · 14 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #77 · Clinical › Prescriber conversations · 25 Jul 2026 · 11 likes post #76 answers the question as asked. The question underneath it is different. Prescription logistics: confirm whether it will be filled locally, requires mail order,…
-
What a reversed-phase purity number actually is Replied, post #92 · Analytics › HPLC & UHPLC · 25 Jul 2026 · 14 likes Method validation is the demonstration that a method can separate the compound from its degradation products and impurities reliably. A method that cannot resolve an…
-
What to bring: records that a clinician can actually use Replied, post #14 · Clinical › Prescriber conversations · 23 Jul 2026 · 19 likes Questions about dose: asking "how will we determine whether this dose is working for me" gets at the monitoring plan. Asking "can we start lower" or "can we escalate…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #98 · Access › International · 21 Jul 2026 · 0 likes I read post #96 twice before replying, because I had assumed the opposite. Customs and import outcomes: different routes have different seizure rates. Some countries…
-
Here for the analytics and not much else Replied, post #64 · Lounge › Introductions · 20 Jul 2026 · 32 likes post #63 answers the question as asked. The question underneath it is different. Following up: if you introduce yourself and someone asks a follow-up question, you can…
-
What a reversed-phase purity number actually is Replied, post #71 · Analytics › HPLC & UHPLC · 19 Jul 2026 · 0 likes Peak purity: a diode-array detector records a spectrum at every time point. If a peak contains two co-eluting species with different spectra, the spectrum changes…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #32 · Sourcing › Regulatory · 17 Jul 2026 · 0 likes I read post #30 twice before replying, because I had assumed the opposite. Off-label use and medical practice: clinicians can prescribe approved medications off-label…
-
Here for the analytics and not much else Replied, post #6 · Lounge › Introductions · 7 Jul 2026 · 31 likes Picking up post #3: that is the part I would want checked first. Privacy: share only what you are comfortable making permanent and public. An introduction is archived…
-
How much context is too much context in a first post? Replied, post #29 · Start Here › How to Ask · 6 Jul 2026 · 20 likes The specific question in the title is more useful than you might think. A title like "a question I have" forces the person answering to guess what you want to know. A…
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #65 · Analytics › Home & field testing · 3 Jul 2026 · 22 likes post #64 is right about the mechanism and I think understates the practical bit. False positives and false negatives: no test has 100% sensitivity and 100% specificity.…
-
Pages past their review date, listed — does this still hold? Replied, post #14 · Meta › Wiki maintenance · 16 Jun 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Research-use-only status: what it means legally and practically Replied, post #58 · Compounds › Other compounds · 14 Jun 2026 · 0 likes This subcategory exists because some people will research compounds outside the main groups discussed here. The standard of evidence and honesty about its limits…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #9 · Sourcing › Independent verification · 9 Jun 2026 · 0 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
Joined after a search result and stayed Replied, post #6 · Lounge › Introductions · 6 Jun 2026 · 7 likes No judgment: people come to this community from all backgrounds and with all motivations. Introductions are for getting to know each other, not for evaluation.
-
Transporting a vial for a weekend away — a second dataset Replied, post #74 · Practice › Storage & stability · 6 Jun 2026 · 0 likes On post #70 — agreed on the reasoning, with one qualification. Container choice matters: the material of the vial, the rubber closure, the fill volume all affect how…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #19 · Practice › Storage & stability · 30 May 2026 · 3 likes Beyond-use dating: the date after which a prepared solution should not be used. It is an estimate based on how fast the solution degrades under stated storage, not on…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #40 · Wellbeing › Sleep · 21 May 2026 · 28 likes This follows post #37 rather than contradicting it. Obstructive sleep apnoea: pre-existing OSA can worsen with weight before it improves (apnoea-hypopnoea index goes up…
-
Conditions that change the calculus rather than forbidding it Replied, post #16 · Safety › Contraindications · 19 May 2026 · 31 likes Worth separating two things that post #12 runs together. Disordered eating history: appetite suppression can trigger relapse in people with history of anorexia,…
-
Revisiting: The arithmetic of an intermediate dose between two label steps Replied, post #14 · Practice › Dosing & titration · 15 May 2026 · 5 likes I read post #12 twice before replying, because I had assumed the opposite. Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the…
-
Two scans six weeks apart on different machines: a cautionary tale Replied, post #17 · Outcomes › Body composition · 13 May 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Journal club: LEADER as the historical anchor Replied, post #67 · Evidence › Journal club · 30 Apr 2026 · 12 likes Coming back to post #65, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
A checklist for reading a certificate in under two minutes Replied, post #7 · Analytics › COA interpretation · 18 Apr 2026 · 3 likes Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide content independent of chromatographic purity. Very…
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #56 · Research Methods › N-of-1 designs · 15 Apr 2026 · 17 likes Statistical analysis of n-of-1 data: comparing before versus after with a t-test or similar is one approach. Plotting the data visually is another. Both are valid.
-
Reconstituting a multi-strength kit without mixing yourself up — what changed since Started this topic · Practice › Reconstitution · 28 Mar 2026 · 23 likes On the subject in the title: Reconstituting a multi-strength kit without mixing yourself up — what changed since Working notes rather than a conclusion. Practical…
-
Where impurities in solid-phase peptide synthesis come from Replied, post #52 · Analytics › Impurities & related substances · 22 Mar 2026 · 0 likes Disulfide formation: if a peptide contains cysteine, it can form disulfide bonds with itself or with other molecules. Under oxidising conditions multiple species…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #14 · Analytics › Mass spectrometry · 17 Mar 2026 · 3 likes Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass is predictable from the base mass.
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #101 · Meta › Site feedback · 16 Mar 2026 · 4 likes Feature requests: if the site would work better with a feature it does not have (better search, different filtering, new section) suggest it here with the reasoning.
-
[2026 update] What a purity-only report leaves out Replied, post #52 · Sourcing › Independent verification · 13 Mar 2026 · 6 likes I read post #50 twice before replying, because I had assumed the opposite. VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than…
-
Angle of injection and whether 90 degrees is always right Replied, post #111 · Practice › Administration · 5 Mar 2026 · 13 likes post #110 is right about the mechanism and I think understates the practical bit. Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue…
-
The lowest dose that does anything: is that a real question? Replied, post #44 · Practice › Dosing & titration · 4 Mar 2026 · 7 likes Worth separating two things that post #40 runs together. The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #12 · Compounds › Semaglutide · 2 Mar 2026 · 0 likes I read post #10 twice before replying, because I had assumed the opposite. Is there a ceiling dose beyond which the effect plateaus? The trials did not study that…
-
Coming back to: Training through a dose escalation week Replied, post #40 · Nutrition & Training › Resistance training · 28 Feb 2026 · 14 likes This follows post #37 rather than contradicting it. Post-weight-loss training: once weight loss is complete and energy deficit ends, training can shift to building…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #96 · Practice › Dosing & titration · 20 Feb 2026 · 0 likes On post #92 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #21 · Sourcing › Vendor reports · 10 Feb 2026 · 7 likes What "verified" means on our pages: specific lots were independently measured on stated dates by named services and results were consistent with the supplier's…
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #73 · Sourcing › Red flags · 1 Feb 2026 · 20 likes Anonymity: a supplier that will not disclose legal name, address, or responsible person is not operating in a way that allows accountability.
-
Documentation that appears only after payment Replied, post #125 · Sourcing › Red flags · 2 Jan 2026 · 5 likes Documentation quality as a signal: a supplier that reports method identifiers, distinguishes specification from result, and states the counter-ion form is telling you…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #43 · Practice › Side effects · 27 Dec 2025 · 18 likes Delayed gastric emptying: the mechanism behind much of the gastrointestinal side-effect profile. At extreme magnitudes, severe gastroparesis is a rare but serious…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #57 · Sourcing › Independent verification · 26 Dec 2025 · 12 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
What "verified" means on our vendor pages, stated narrowly Replied, post #10 · Sourcing › Vendor reports · 26 Dec 2025 · 0 likes Worth separating two things that post #6 runs together. Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water,…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #30 · Practice › Dosing & titration · 20 Dec 2025 · 3 likes Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives. Before that, the concentration is rising with each dose.…
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #20 · Data & Tools › Calculators · 20 Dec 2025 · 0 likes post #19 is right about the mechanism and I think understates the practical bit. Titration planning: a calculator that shows you the escalation schedule for different…
-
Second pass at: Fasting versus non-fasting and which tests care Replied, post #2 · Clinical › Bloodwork · 8 Dec 2025 · 13 likes I read the opening post twice before replying, because I had assumed the opposite. Renal function markers: eGFR is estimated, not measured. It depends on creatinine,…
-
How to read a forest plot, properly, from scratch Replied, post #61 · Evidence › Trials · 26 Nov 2025 · 1 like Dropout is information: high dropout rates can indicate tolerability problems or lower efficacy than the summary suggests. Where the analysis handled dropouts matters.…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #33 · Practice › Reconstitution · 24 Nov 2025 · 6 likes Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
-
Specification in the result column: why that is a meaningful error Replied, post #74 · Analytics › COA interpretation · 16 Nov 2025 · 27 likes When a document puts the specification in the result column, it has told you the release criterion, not the measurement. Those are different claims and the second is…
-
Sleep tracking data and its considerable limitations Replied, post #80 · Wellbeing › Sleep · 25 Oct 2025 · 18 likes Worth separating two things that post #76 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Appeal templates and why they are deliberately unemotional Replied, post #17 · Access › Insurance & coverage · 3 Oct 2025 · 12 likes Coverage for weight management versus diabetes: many formularies cover these compounds for type 2 diabetes but not for weight management. The indication matters and…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #60 · Evidence › Study critique · 14 Sep 2025 · 9 likes Criticise the method, not the author: a paper with a weak design is not a bad paper by someone with bad intentions. It is a paper that answers a limited question.…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #141 · Data & Tools › Datasets · 11 Sep 2025 · 0 likes Using data in discussions: datasets are useful as reference points when someone claims something unusual. "I have not seen that reported in the data" is different from…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #27 · Lounge › Off topic · 9 Sep 2025 · 16 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
What pooling buys you and what it destroys Replied, post #13 · Evidence › Meta-analyses · 31 Aug 2025 · 1 like post #12 is right about the mechanism and I think understates the practical bit. Pooled estimates and heterogeneity: when trials differ in population, duration, or…
-
Enforcement priorities versus written rules — does this still hold? Replied, post #29 · Sourcing › Regulatory · 26 Aug 2025 · 12 likes Primary documents matter: regulatory positions are published in official documents. Reading the regulatory agency's website directly is more reliable than reading a…
-
A field-by-field walk through a certificate of analysis Replied, post #110 · Analytics › COA interpretation · 17 Jul 2025 · 1 like Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #25 · Sourcing › Vendor reports · 14 Jul 2025 · 8 likes post #24 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
[2026 update] Constipation management, with a dietitian's contribution Replied, post #10 · Practice › Side effects · 11 Jul 2025 · 14 likes Constipation: common, manageable, and frequently under-reported because it is not dramatic. Increasing fibre and fluid intake helps. Over-the-counter management is…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #27 · Practice › Reconstitution · 1 Jul 2025 · 0 likes I read post #25 twice before replying, because I had assumed the opposite. How much of the diluent volume the powder itself displaces: for a small peptide vial, the…
-
The C-cell question: rodent findings and their human context Replied, post #32 · Compounds › Semaglutide · 27 Jun 2025 · 25 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Area percent versus weight percent: the confusion that causes most arguments — what… Replied, post #2 · Analytics › HPLC & UHPLC · 22 Jun 2025 · 11 likes This is why a purity figure without the underlying chromatogram is weaker evidence than it appears. It is also why two competent laboratories can report different…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #66 · Practice › Reconstitution · 8 Jun 2025 · 2 likes Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #36 · Compounds › Cagrilintide & amylin analogues · 7 Jun 2025 · 22 likes I read post #34 twice before replying, because I had assumed the opposite. The CagriSema phase 2 paper: a fixed combination of the two components in one weekly…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #36 · Evidence › Trials · 6 Jun 2025 · 18 likes Picking up post #33: that is the part I would want checked first. Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false…
-
Follow-up: What is genuinely unknown about long-term amylin agonism Replied, post #2 · Compounds › Cagrilintide & amylin analogues · 30 May 2025 · 31 likes What is genuinely unknown about long-term amylin agonism: real-world response rates, whether effect is durable with continued use, whether satiety adaptation occurs…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #100 · Practice › Interactions · 25 May 2025 · 20 likes post #99 is right about the mechanism and I think understates the practical bit. SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular…
-
Payment mechanics and the recovery options that do not exist — what changed since Replied, post #10 · Sourcing › Payments · 20 May 2025 · 7 likes Documentation and tax implications: payments you make for compounds might have implications for tax reporting depending on your jurisdiction. Keeping clear records…
-
A ten-fold dose error caught before injection Replied, post #33 · Devices › Syringes & needles · 12 May 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #10 · Practice › Reconstitution · 8 May 2025 · 1 like Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
-
A report I filed that turned out to be wrong, and the correction Replied, post #30 · Sourcing › Vendor reports · 27 Apr 2025 · 25 likes What "verified" means on our pages: specific lots were independently measured on stated dates by named services and results were consistent with the supplier's…
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #35 · Compounds › Cagrilintide & amylin analogues · 27 Apr 2025 · 4 likes On post #31 — agreed on the reasoning, with one qualification. Reading the phase 2 paper: it establishes tolerability and efficacy in a selected population on a defined…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #37 · Compounds › Retatrutide · 13 Apr 2025 · 9 likes Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material with no human-use authorisation. This site will state that…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #46 · Compounds › Tirzepatide · 25 Mar 2025 · 1 like The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal at that dose. It is a tolerance-testing dose. Confusing the purpose of a…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #133 · Compounds › Semaglutide · 20 Mar 2025 · 1 like This follows post #130 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Coming back to: An 18-month record including the parts that went badly Replied, post #26 · Outcomes › Progress reports · 11 Mar 2025 · 2 likes Longitudinal report with the method stated: same scale, same time of day, same conditions. A scale is a tool; use the same one each time. Consistency matters more than…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #10 · Clinical › Comorbidities · 7 Feb 2025 · 15 likes I read post #8 twice before replying, because I had assumed the opposite. Multiple comorbidities: a person with diabetes, kidney disease, and cardiovascular disease is…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #3 · Access › Pricing · 3 Feb 2025 · 16 likes Coming back to the opening post, because the follow-up matters more than the original answer. Discount programmes and coupons: manufacturers often offer coupons that…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #85 · Analytics › COA interpretation · 30 Jan 2025 · 15 likes When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #9 · Practice › Reconstitution · 29 Jan 2025 · 3 likes Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection. Isotonic solutions (close to blood osmolarity) are less…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #27 · Compounds › Semaglutide · 14 Jan 2025 · 15 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Transit times by route, from a logged dataset — the long version Replied, post #48 · Sourcing › Logistics · 11 Jan 2025 · 8 likes Packaging integrity on arrival: if a parcel arrives with compromised packaging, that is evidence of a handling problem in transit. The contents may or may not be…
-
Triple agonism: additive, synergistic, or neither? Replied, post #9 · Compounds › Retatrutide · 8 Jan 2025 · 25 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
When "no data" is the complete and final answer Replied, post #61 · Compounds › Other compounds · 8 Jan 2025 · 8 likes post #60 answers the question as asked. The question underneath it is different. How to research a compound with no human data: mechanistic plausibility is one input.…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #35 · Wellbeing › Mental health · 6 Jan 2025 · 0 likes Substance use: if someone has a history of substance use, appetite suppression and weight loss can shift thinking about body and substance use. This is a risk factor…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #50 · Access › Shortages · 10 Oct 2024 · 5 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #29 · Compounds › Tirzepatide · 7 Oct 2024 · 0 likes The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal at that dose. It is a tolerance-testing dose. Confusing the purpose of a…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #38 · Devices › Syringes & needles · 21 Sep 2024 · 12 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
High-resolution MS on aggregates and what it can see — one year on Replied, post #13 · Analytics › Mass spectrometry · 12 Aug 2024 · 23 likes Purity and identity are different questions: LC-MS establishes that the species at a retention time has the expected mass. It does not establish how much of the sample…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #44 · Compounds › Retatrutide · 19 Jul 2024 · 31 likes The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that attracted attention. It also reported dose-dependent heart-rate increases. The…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #18 · Clinical › Prescriber conversations · 10 Jul 2024 · 18 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #114 · Practice › Dosing & titration · 10 Jul 2024 · 2 likes The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long…